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INTRODUCTION
Foreign antigens derived from the diet and the microbiota pose a daily challenge to the gastrointestinal tract. Regulatory T cells (T regs ), abundant in the gut mucosa, prevent inflammatory bowel disease and food allergies through inhibition of harmful responses by effector T cells (1, 2) . CD4 + T cells exhibit plasticity and can differentiate into distinct subsets with diverse functional properties (3, 4) . The intestinal lamina propria (LP), a location constantly exposed to commensal antigens, harbors many T cell subsets [e.g., T helper cell 1 (T H 1), T H 17, and peripheral Foxp3 + regulatory T cell (pT reg )] living in relative harmony. How these T cell fates are determined in vivo is the subject of intense study, as is the role of T cell receptor (TCR) specificity in this process. The TCR repertoire of colonic T regs shows little, if any, overlap with the repertoire of naïve or effector CD4 + T cells present at the same location or with T regs isolated from organs other than the intestine (5) . Likewise, the repertoire of intestinal T H 17 differs substantially from that of other intestinal T cells (6) . Whereas colonic commensals such as Clostridium spp. favor pT reg development (5, 7), segmented filamentous bacteria (SFB) induce differentiation of conventional CD4 + T cells (T convs ) into quasi-clonal T H 17 in the small intestine (6, 8) . Thus, the repertoire and fate of CD4 + T cells in the intestinal LP are determined by the microbiota. Fate decisions appear to be made at the clonal level so that different TCR specificities determine different developmental outcomes. The mechanism whereby TCR specificity drives T cell fate and function is unclear and may depend on the relative abundance of the antigens recognized, environmental cues, or a combination of both.
Development and expansion of thymus-derived or natural T regs (nT regs ) are limited by intraclonal competition (9, 10) . This process is driven by affinity for self-ligands: the higher the affinity for the antigen, the larger the nT reg "niche" size (11) . When antigen presentation occurs under subimmunogenic or noninflammatory conditions, T convs may differentiate into pT regs (1) . If and how the identity of the TCR dictates cell fate among T convs remains unsettled, as does the role of TCR specificity in determining the pT reg phenotype.
To address these questions, we generated a monoclonal mouse line cloned from a pT reg nucleus and thus bearing the prerearranged TCR of a pT reg . We found that this TCR facilitates conversion of CD4 + T cells into CD4 +
CD8aa
+ intraepithelial lymphocytes (CD4 IELs ) while, at the same time, allowing development of pT reg in the mesenteric lymph nodes (mLNs) and small intestine LP (siLP), all in a microbiotadependent manner. Thus, a single TCR specificity can give origin to two distinct T cell phenotypes in two distinct anatomical locations.
RESULTS
We used somatic cell nuclear transfer (SCNT) to generate a transnuclear (TN) mouse line that carries a TCR cloned from the nucleus of a pT reg lymphocyte, isolated from the intestine-draining mLNs of a healthy, unmanipulated Foxp3-GFP (green fluorescent protein) reporter mouse ( fig. S1A ). To simplify the identification of the TCRa in the SCNT-derived mouse, we sorted CD4 + CD8a − Foxp3-GFP , as previously reported (12) . The resulting pT reg TN mouse line carries prerearranged endogenous TCRa and TCRb loci that assemble into a functional receptor, as shown for other TN mouse lines (13, 14) .
Resulting chimeras from SCNT were bred to C57BL/6 wild-type (WT) mice to obtain germline transmission ( fig. S1C ). TN mice were crossed to Rag1-deficient mice to preclude secondary TCR rearrangements ( fig. S1A ). We used these TN mice ( fig. S1A ) to investigate the role of the TCR in determining the fate of conventional CD4 + T cells.
Nearly all T cells in the peripheral lymphoid organs of these TN mice were CD4 + CD8a − and carried a monoclonal Va2 Vb6 TCR pair with unique CDR3 sequences (referred to hereafter as pT reg TN/RKO mice; fig. S1 , A and D, and Fig. 1A ). pT reg TN/RKO mice are viable and fertile and show no signs of overt autoimmune or wasting disease (follow-up >8 months after birth). Despite having been cloned from a Foxp3 + pT reg , no Foxp3 + cells could be detected in these mice in any of the organs analyzed (Fig. 1A and fig. S1E ). To rule out an intrinsic inability of the TN cells to become Foxp3 + T reg , we purified naïve CD4 + T cells from spleens of pT reg TN/RKO mice and induced T reg differentiation in vitro. Activation with anti-CD3 and anti-CD28 in the presence or absence of transforming growth factor-b (TGF-b) and interleukin-2 (IL-2) elicited proliferation of naïve TN CD4 + T cells to the same extent as WT polyclonal cells. Conversion into Foxp3 + T reg was readily observed in the presence of TGF-b and IL-2 ( fig. S1F) The development of thymus-derived nT reg can occur only when the number of precursors bearing the same TCR rearrangement is small (9, 10) . To determine whether this is the case for pT reg development from our TN TCR, we reconstituted sublethally irradiated TCRabKO recipients with bone marrow preparations containing a mixture of cells from polyclonal (WT) and monoclonal pT reg TN/RAGKO donors [or ovalbumin (OVA)-specific OTII RAGKO donors as a control] in different proportions and analyzed T cell development at 12 weeks after reconstitution (see Materials and Methods and Fig. 1 , B to D). No T reg development was observed in any organ when the monoclonal precursors were OTII RAGKO, regardless of the degree of chimerism (Fig. 1, B and C) , consistent with the idea that generation of pT reg requires exposure to antigen (12, 15) . In contrast, T reg development from TN precursors was readily observed but only when the TN/WT ratio (2.5/97.5) was low. Polyclonal precursors gave rise to T reg regardless of the degree of chimerism (Fig. 1, B to E). Although low precursor frequency facilitated some T reg development in inguinal LNs (iLNs) and spleen, T reg frequencies at these sites were much lower than those in mLN ( fig. S2 , A to C). No TN T regs were found in the thymus, regardless of the extent of chimerism ( Fig. 1E and fig. S2 , A and B), indicating that this particular TCR does not support nT reg development, a further argument in favor of the notion that the quality of the TCR contributes to setting T cell fate.
We next analyzed whether TN pT reg could also accumulate at the intestinal mucosa, given that their TCR was originally derived from a pT reg in the intestine-draining mLN. Again, the development of pT reg was dependent on low precursor frequencies and was seen only in the siLP, whereas very few pT regs were found in the large intestine LP (liLP) (Fig. 1, B and C) . We conclude that, for this particular TCR, low clonal frequencies are a prerequisite for generation of pT reg in peripheral lymphoid organs and in the siLP. Given a previous report of nichedependent pT reg generation in the colon (5), it is likely that precursor frequency effects are a common property of pT reg development in the gut.
The absence of pT reg in the monoclonal pT reg TN/RKO mice ( Fig.  1 and fig. S1 ) prompted us to investigate whether CD4 + TN cells could adopt a phenotype other than that of a T reg in vivo. In lymphoid organs (mLN, iLN, and spleen), the vast majority of the TN cells retained a naïve CD44 low phenotype ( Fig. 2A) . Because the mLN drains the intestine, we analyzed LP and intraepithelial (IE) compartments for the presence and phenotype of the TN cells. The few TN cells present in the liLP had a naïve phenotype, whereas CD4 + TN T cells were abundant in the siLP and IE and expressed high levels of CD44 ( Fig. 2A) . Although no Foxp3 + T regs were present in the siLP and IE compartments (Fig. 2 , B and C), unexpectedly, >50% of TN CD4 + T cells at these sites coexpressed CD8a (but not CD8b), and almost all of these produced interferon-g (IFN-g) (Fig. 2, B to D) . Only mice older than 10 weeks of age displayed these traits (Fig. 2, C and D, and fig. S3, A and B) . In younger mice, CD4 + T cells remained CD4 single-positive (SP) with a naïve phenotype and did not produce IFN-g (Fig. 2, A and D) . The trigger for differentiation and IFN-g production is therefore likely to be a foreign antigen that accumulates over time, rather than a selfantigen present since birth. We did not detect production of IL-17A by TN cells isolated from siLP or IE (Fig. 2D ), yet these cells had no intrinsic defect in making IL-17 when stimulated in vitro under T H 17-polarizing conditions ( fig. S3C ). Therefore, in the small intestine, the TN TCR naturally favors the efficient conversion of CD4 + T cells into IFN-g-producing CD4 IELs rather than into Foxp3 + pT regs . Production of IFN-g is consistent with the cytotoxic phenotype reported for IEL (16) . Despite massive expansion of these IFN-g producers in the small intestine, pT reg TN/RKO mice showed no signs of overt inflammatory or wasting disease. Tissue architecture was preserved with no signs of epithelial disruption (Fig. 2E) . Levels of fecal lipocalin-2 (LCN2), a sensitive marker of intestinal inflammation (17) , were low and similar to those in WT mice (Fig. 2F) , confirming the absence of intestinal inflammation in our pT reg TN/RKO mice.
Using the mixed bone marrow chimera approach (Fig. 1) , we analyzed the niche dependency of the conversion of TN precursors into CD4 IELs . In sharp contrast to pT reg development (Fig. 1) 
CD8a
+ T cells emerged not only in the IE but also in the siLP (and less so in the liLP), irrespective of the extent of chimerism (Fig. 2, G to I 
+ T cells emerged from the OTII bone marrow (Fig. 2G) TN cells cloned from an mLN pT reg yield not only pT reg but also CD4 IEL in the small intestine, in the absence of any exogenous stimulation or immunization (Figs. 1, B to E, and 2, A to D, H, and I). The TN TCR might therefore recognize an antigen constitutively present at these sites. We tested the ability of TN cells to undergo homeostatic expansion in lymphopenic hosts (18) , which requires TCR engagement. We adoptively transferred naïve CD4 + T cells isolated from spleens and mLNs of pT reg TN/RKO or WT mice into TCRabKO recipients and analyzed the recovery of TN cells from different anatomical sites 6 to 8 weeks after transfer. We found TN cells to be abundant in the siLP and IE but less so in the liLP ( fig. S4, A When transferred into immunocompetent WT hosts, pT reg TN CD4 + cells proliferated in the mLN but not in the iLN, as measured by carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution 5 days after adoptive transfer (Fig. 3, A and B) . We also observed expansion and differentiation into CD4 IEL in the intestinal mucosa as well as into pT reg in the mLN ( S5C ). The late development of CD4 IEL observed in the pT reg /RKO mice, together with the absence of any overt disease, suggested that the antigen recognized by the TN TCR was neither a dietary nor a self-antigen. We therefore investigated whether expansion and conversion of TN cells in TCRabKO hosts depended on the resident microbiota. We treated TCRabKO recipients of TN cells with a cocktail of antibiotics to deplete the microbiota (19) . Efficiency of treatment was confirmed by the absence of bacterial colony growth under aerobic and anaerobic conditions and by a reduction of at least one log in 16S ribosomal DNA amplification from fecal samples when compared with untreated mice (see Materials and Methods) ( fig. S6, A and B) . We adoptively transferred naïve CD4 + T cells isolated from pT reg TN/RKO mice into antibiotic-treated or untreated recipients (Fig. 4A) . TN cells expanded and converted into pT reg and CD4 IEL in untreated mice, but TN T cells failed to do so in antibiotictreated recipients. The few cells that did migrate to the small intestine remained Foxp3 − and CD8a − (Fig. 4B) . Conversion into pT reg and CD4 IEL thus depends on the microbiota, suggesting that this TN TCR recognizes a bacterial antigen. To confirm this, we adoptively transferred CFSE-labeled CD4 + TN cells into TCRabKO recipients previously treated or not with antibiotics for 7 to 14 days (Fig. 4C) . As expected, transferred TN cells proliferated extensively in the mLN of untreated mice but not in antibiotic-treated mice. Proliferation of TN cells in antibiotic-treated mice was rescued by immunization with sonicated bacterial extracts obtained from fecal pellets or cecum lavage of Taconic mice with excluded flora (EF) (see Materials and Methods) (Fig. 4D) . Extensive TN T cell proliferation was also triggered in iLN by subcutaneous immunization of both TCRabKO and WT recipients, whereas no proliferation was observed in iLN of nonimmunized mice (Fig. 4, E to H) . Last, TN T cell proliferation was also inducible in vitro by coculture with dendritic cells (DCs) in the presence of sonicated fecal extracts from Taconic EF but not from germfree (GF) mice (Fig. 4, I and J). Bacterial antigen extracts derived from feces of mice housed in different animal facilities induced different degrees of proliferation in TN cells, but never to the same extent as the Taconic EF ( fig. S7 , A to C), possibly reflecting differential abundance of the targeted commensal in mice with different microbiota. No proliferation was observed in the absence of DCs or when DCs were deficient in MHCII (Fig. 4, I and J, and fig. S7A ). Proliferation induced by Taconic EF bacterial extracts was abolished by treatment with trypsin and by heat inactivation (fig. S7D ). The relevant microbial antigen is therefore likely to be a protein that requires internalization, processing into peptides, and presentation at the cell surface via MHCII products. When RAGKO mice purchased from Taconic Biosciences or Jackson Laboratory (and kept in microisolators) were adoptively transferred with naïve CD4 + T cells isolated from pT reg /RKO mice, TN T cells expanded and converted into CD4 IEL in Taconic recipients but not in Jackson Laboratory recipients. Expansion and conversion were readily observed in Jackson Laboratory mice cohoused with Taconic mice ( fig. S8A ). We conclude that the antigen recognized by the pT reg TN TCR is a protein derived from the intestinal microbiota prevalent in Taconic mice.
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We used RNA sequencing (RNA-seq) to characterize the pT reg and CD4 IEL that had differentiated from the same clonal TN precursor and recovered from the intestinal mucosa. We adoptively transferred CD4 + CD8a − Foxp3-GFP − isolated from pT reg TN/ RKO/Foxp3-GFP mice into TCRabKO hosts. After (Fig. 6, A to E) , corroborating results obtained for WT IELs (16, 22) . In our system, converted pT regs did not up-regulate retinoid-related orphan receptor g t (RORgt) expression (Fig. 6F) , the transcription factor of T H 17 and expressed by a fraction of intestinal pT regs (21, 23, 24) . We conclude that adoptive transfer of TN T cells leads to differentiation and expansion of bona fide pT reg and CD4 IEL T cells from the same clonal precursors.
The preferential conversion into pT reg or IFN-g-producing CD4 IEL in vivo and the absence of T H 17 conversion were not due to a lack of SFB colonization of our recipient mice, as a quantitative polymerase chain reaction (qPCR) assay specific for SFB readily detected them in the TCRabKO mice housed in our facility, but less so or not at all in EF mice purchased from Taconic ( fig. S9A) .
The ability of TN T cells to differentiate into both the pT reg and the CD4 IEL of selected genes known to be up-regulated in the indicated T cell subsets are shown.
crossed the pT reg TN/RKO mice to RAGKO/scurfy (Foxp3-deficient) mice and used the resulting offspring as donors of CD4 + T cells that were adoptively transferred into TCRabKO hosts. Although TN cell expansion was unaffected in these hosts (Fig. 7 , A to C), CD4 + T cells no longer converted into pT reg . However, differentiation of CD4 IEL occurred to the same extent as in Foxp3-sufficient mice (Fig. 7D) . Development of CD4 IEL is thus Foxp3-independent.
The massive expansion of IFN-g-producing TN T cells in the siLP and IE compartment of pT reg TN/RKO mice or in TCRabKO mice transferred with TN T cells causes neither wasting disease nor disruption of epithelial integrity (Figs. 2, D and E, and 7, E and G). This is in contrast to the colitis model induced by T reg -depleted polyclonal T cells transferred into immunodeficient hosts (25). Thus, it was possible that the pT reg generated in TCRabKO mice transferred with TN T cells might have prevented excessive inflammation or disease caused by the CD4 IEL . Despite increased production of IFN-g in the IE compartment, mice that received Foxp3-deficient TN cells showed no signs of disease 8 to 12 weeks after transfer (Fig. 7, E to H). Histopathological analysis of the intestine showed extensive lymphocyte infiltration of the LP in both groups to the same extent but no signs of epithelial disruption (Fig. 7G) . Mice that received either Foxp3-deficient or Foxp3-sufficient TN CD4 + T cells also had overall similar levels of LCN2 in the feces (Fig. 7H) . Therefore, despite their activated status and robust production of IFN-g, CD4 IELs derived from the pT reg TN/RKO mice are not overtly pathogenic, even in the absence of Foxp3 + T reg , presumably related to the absence of recognition of a self-antigen in the gut and to their potential regulatory properties.
DISCUSSION
We show that T cell precursors of TN mice cloned from and bearing the TCR rearrangements of a mLN peripheral T reg can adopt two distinct fates (pT reg and CD4 IEL ) upon encounter with microbial antigen in the intestinal environment. We believe that our experiments have identified a compelling example of a naturally occurring pT reg TCR that promotes spontaneous CD4 IEL conversion in response to a component of the microbiota.
The unimpaired differentiation of CD4 IEL from Foxp3-deficient TN precursors suggests that the pathways that lead to CD4 IEL differentiation in this case are independent of pT reg conversion. However, pT reg can acquire the CD4 IEL phenotype in a microbiota-dependent manner (26) , indicating that there is more than one pathway for CD4 IEL development. Although the TN pT reg and CD4 IEL presumably recognize the same bacterial species, these populations accumulate in distinct anatomical locations-mLN and intestinal epithelium, respectively. Whether this dichotomy is due to the independent priming of pT reg and CD4 IEL in situ at each of these locations or is due to migration to distinct sites after priming in the mLN is unclear. One possibility is that priming in the mLN may give rise simultaneously both to pT reg and to undifferentiated but activated T cells that will further acquire the CD4 IEL phenotype upon a second encounter with the bacterial antigen in the intestine. Alternatively, antigen presentation by different antigen-presenting cell (APC) subsets in distinct microenvironments may promote independent differentiation of the two cell types. Previous work using a TCR transgenic model showed that the extracellular commensal SFB drive the intestinal T cells to adopt the T H 17 program, whereas infection with the intracellular pathogen Listeria monocytogenes expressing the SFB epitope directs the same SFB-specific cells toward T H 1 (6) . Thus, in this model, monomorphic differentiation of T cells is directed by the changes in the environment in which T cell priming occurs. The constantly stimulated epithelial environment could be both inhospitable for pT reg and favorable for CD4 IEL differentiation, whereas the mLN favors pT reg differentiation and allows the accumulation of pT regs at that site. Whether and how the relative abundance of ligands (5, 6), TCR-independent factors such as microbial metabolites (27, 28) , and cell-intrinsic mechanisms, as well as the different types of APCs (29) (30) (31) , cooperate to define T cell fate in the gut environment remain to be determined.
Although pT reg development is dependent on low precursor frequencies, CD4 IELs carrying the identical TCR are not limited in any way by clonal size. Intrinsic properties of the T cell subset concerned can thus directly affect their expansion. Development of nT reg requires small niche sizes (9, 10), possibly due to intraclonal competition for a limited amount of ligands. Development of Clostridium-specific pT reg also appears to be dependent on small clonal sizes (5). In contrast, when clonal sizes are larger, CD4 + T cells no longer convert into T regs and remain as effector or naïve T cells. Therefore, the small niche requirement may be a common property of T reg populations. Although relative abundance for ligands is suspected to play a major role in T reg development, the precise mechanisms at play remain to be unveiled.
Dietary antigens may stimulate the bulk of pT regs present in the small intestine (24) , whereas induction of colon pT regs depends almost exclusively on the microbiota (5, 7) . However, constant stimulation by the microbiota in the small intestine can also allow for the generation of microbiota-specific pT regs at this site. On the basis of experiments using GF and antigen-free mice, it is estimated that a sizable proportion of pT reg in the siLP is induced by the microbiota and expresses RORgt (21, 23, 24) . We report a different lineage of pT regs that does not (26) , express RORgt and/or could interconvert into T H 17-like cells.
Premature expression of TCRa in transgenic mice may contribute to the development of unconventional IELs (32, 33) . However, unlike the TN cells in our mice, these cells predominantly consist of unconventional IELs that expressed only CD8aa. Moreover, we show microbiota-dependent CD4 IEL differentiation from mature CD4 + T cells isolated from secondary lymphoid organs (spleen and mLN), thus discounting a potential role for direct development of CD4 IEL from DN (double-negative) or DP thymic precursors in our model. Accordingly, CD4 IELs are absent in GF and antibiotic-treated WT mice (16) . The microbiota must play a specific role in the generation/ expansion of this T cell subset. CD4 + T cells isolated from an unrelated TN line cloned from a pancreatic tumor-infiltrating lymphocyte fail to convert to CD4 IELs , demonstrating that CD4 IEL differentiation is directed by TCR specificity.
Mice harboring microbiota-specific TN cells remain healthy despite massive accumulation of IFN-g-expressing CD4 IEL and irrespective of the presence of T regs . This suggests that additional factors may suppress pathogenic inflammation in the intestine, for example, by inducing a regulatory response related to the CD4 IEL phenotype. IFN-g-producing IELs can display regulatory functions rather than proinflammatory activity (34) . Using a model antigen (OTII and OVA) in which antigen-specific T reg development was impaired by the scurfy mutation, antibody-mediated depletion of CD4 IEL led to intestinal inflammation and diarrhea (26) , suggesting a regulatory role for CD4 IEL . Although the mechanisms by which CD4 IEL and other IELs regulate the immune response at intestinal surfaces remain to be fully elucidated, our studies showcase the importance of location in determining T cell fate and functions.
MATERIALS AND METHODS

Study design
The present study was designed to investigate the extent to which TCR identity dictates pT reg fate in vivo. We conducted adoptive transfer experiments and in vitro proliferation assays and used FACS analyses and RNA-seq as described in the figure legends. As indicated in the figures and figure legends, the number of mice per experiments varied from 2 to 14 per experimental group. All experiments were repeated at least once. Mice were arbitrarily assigned to each experimental group, and both males and females were used for the experiments. All data obtained are presented, including outliers. For the in vitro proliferation assays, experiments were performed in duplicate and repeated two to three times.
Mice TN mice for pT reg TCR (pT reg TN) were generated by SCNT in a mixed C57BL/6 and 129 background as described ( fig. S1) (14) . All mice were housed at the Whitehead Institute for Biomedical Research (WIBR) under specific pathogen-free conditions, and all procedures were approved and performed according to the Institutional Animal , and scurfy mice were purchased from Taconic Biosciences and Jackson Laboratory and maintained at our facility. Tcra −/− and Tcrb −/− were intercrossed to originate Tcra
Foxp3 gfp mice were generated as described (35) . pT reg TN mice were backcrossed at least for six generations into C57BL/6 RAG1KO background. PancCD4 TN mouse was cloned from pancreatic tumor-infiltrating CD4 + T cells and used as a control in fig. S4 . They were generated by SCNT in a mixed C57BL/6 and 129 background as described (14) and backcrossed at least for six generations into C57BL/6 RAG2KO background.
Antibodies, reagents, and FACS analysis Fluorescent dye-conjugated antibodies were purchased from BD Biosciences (anti-Vb6, RR4-7; anti-CD69, H1.2F3; anti-CD3, 145-2C11; anti-Vb5, MR9-4; anti-IL-17, TC11-18H10; and anti-ThPOK, T43-94), eBioscience (anti-CD45.1, A20; anti-Foxp3, FJK-16s; antiKi-67, Sol A15; anti-CD4, RM4-5; Va2, B20.1; anti-CD19, eBio1D3; anti-CD11c, N418; anti-IFN-g, XMG1.2; and anti-Va11, RR 8-1), or BioLegend (anti-CD45.2, 104; anti-CD8a, 53-6.7; anti-CD8b, YTS 156.7.7; anti-CD44, IM7; anti-I-A/I-E, M5/114.15.2; and anti-Va8.3, KT50). Cell dyes CFSE and CellTrace Violet for proliferation assays were purchased from Sigma-Aldrich and Life Technologies, respectively. Cell viability dye 7-AAD (Via-Probe) was purchased from BD Biosciences. Flow cytometry data were acquired on an LSRFortessa (Becton Dickinson) instrument and analyzed with the FlowJo software package (Tri-Star). Staining with cell proliferation dyes was performed according to the manufacturer's instructions. Staining for surface markers was performed at 4°C for 25 to 30 min. Intracellular staining of Foxp3 and Ki-67 staining were performed with Foxp3/ Transcription Factor Staining Buffer Set (eBioscience), and intracellular cytokine staining was performed with Cytofix/Cytoperm Kit (BD Biosciences), according to the manufacturer's instructions. For the cytokine staining, cells were incubated with phorbol 12-myristate 13-acetate (100 ng/ml; Sigma), ionomycin (200 ng/ml; Sigma), and 2 mM monensin (Sigma) for 4 hours at 37°C. Monensin was added for the last 2 hours of incubation.
Antibiotic treatment
Vancomycin (0.5 g/liter), ampicillin (1.0 g/liter), neomycin (1.0 g/liter) (Amresco), and metronidazole (1.0 g/liter) (Sigma) cocktail was given ad libitum in the drinking water for 7 to 14 days or for 6 to 8 weeks as indicated in the figure legends.
Quantification of fecal LCN2 LCN2 was measured in fecal homogenates as described (17) using the Mouse Lipocalin-2/NGAL DuoSet ELISA (enzyme-linked immunosorbent assay) kit according to the manufacturer's protocol (R&D Systems, Minneapolis, MN).
Isolation of mononuclear cells from intestine
Small and large intestines were harvested, and mononuclear cells were isolated from LP as previously described (36) . IELs were recovered from the supernatants of 1 mM dithiothreitol and 30 mM EDTA washes.
16S and SFB qPCR of fecal DNA DNA was extracted from fecal pellets using the Zymo Research Fecal DNA Isolation Kit, according to the manufacturers' protocol. qPCR was performed using SYBR Green Master Mix (Bio-Rad). Primer sequences used for 16S were 5′-gtgStgcaYggYtgtcgtca-3′ and 5′-acgtcRtccMcaccttcctc-3′ (37), and those used for SFB were SFB225F 5′-aggaggagtctgcggcacattagc-3′ and SFB558R 5′-cgcatcctttacgcccagttattc-3′ (38) .
Stool test for bacterial growth
Single fecal pellets were resuspended into 500 ml of phosphate-buffered saline (PBS) and spun briefly to remove fibers. Supernatant was diluted 1:10 and 1:100 and then streaked on brain-heart infusion plates and incubated under aerobic and anaerobic conditions. After 48 to 72 hours, plates were examined for colony growth.
Bacterial extracts for proliferation assays Feces (2 to 10 pellets) from healthy WT or Rag1 −/− mice housed at different animal facilities (WIBR, Jackson Laboratory, and Taconic Biosciences) were homogenized in PBS and shaken at 2000 rpm for 20 min at 4°C. Large debris was removed by centrifugation (700g, 1 min). Supernatants were centrifuged at 13,500g for 10 min at 4°C, and bacterial pellet was resuspended in 1 ml of PBS containing protease inhibitors (cOmplete Mini, Roche; 1 tablet per 10 ml of PBS following the manufacturer's instructions) and deoxyribonuclease I (Roche). Bacteria were lysed by three rounds of sonication (Branson Sonifier 450) for 1 min, 60 pulses, followed by 5 min of cooling on ice between each round (output control, 4; duty cycle, 50%). Cellular debris was removed by centrifugation at 14,000g for 30 min at 4°C. Protein concentration was measured by bicinchoninic acid assay (BCA) and used for in vitro and in vivo proliferation assays as indicated. In some experiments ( fig. S7) , bacterial extracts were subjected to trypsin or heat inactivation treatment before being used in in vitro proliferation assays. For trypsin treatment, bacterial extract (50 mg/ml; prepared in the absence of protease inhibitor) was incubated with trypsin (2.5 mg/ml) for 4 hours at 37°C. Trypsin was inactivated by adding protease inhibitor as described above. For heat inactivation, bacterial extracts were boiled for 20 min and then centrifuged at 14,000g for 10 min at 4°C. Supernatant was collected, and pellet was resuspended in PBS containing protease inhibitors and sonicated in a water bath sonicator for 10 min. Supernatants and resolubilized pellets were used for the in vitro proliferation assays at a maximum of 20 ml per well.
In vitro proliferation assay DCs were purified with the Pan Dendritic Cell Isolation Kit (Miltenyi Biotec) from spleens of WT mice injected with 1 × 10 6 B16-FLT3L cells. T cells were purified with the Naïve CD4 + T Cell Isolation Kit (Miltenyi Biotec) from the spleens and mLNs of pT reg TN/RKO mice and labeled with 2.5 mM CFSE (Sigma). Purity was always greater than 98% for both DCs and T cells. DCs (1 × 10 5 ) were incubated with sonicated bacterial extracts (25, 50, or 100 mg/ml) for 2 hours before the addition of 1 × 10 5 TN CD4 + T cells. Cell division was assessed by CFSE dilution and analyzed by flow cytometry after 3.5 days of coculture.
In vivo proliferation assay TCRabKO or WT mice were treated with a cocktail of antibiotics (ampicillin, 1 g/liter; metronidazole, 1 g/liter; neomycin, 1 g/liter; and vancomycin, 0.5 g/liter) for 1 to 2 weeks and adoptively transferred with 5 × 10 5 CFSE-or CellTrace Violet-labeled T cells. One day later, mice were immunized with 50 mg of sonicated bacterial extract adsorbed in alum (Imject, Thermo Fisher Scientific). Bacterial extracts used for immunization were obtained from fecal pellets of WT mice (EF health status) purchased from Taconic. Cell division and activation markers were measured 5 days after adoptive transfer by flow cytometry.
Isolation of CD4
+ T cells Naïve CD4 + T cells were purified from the spleen and mLN using the Naïve CD4 Isolation Kit according to the manufacturer's instructions (Miltenyi, Germany). Purity was always greater than 98%. In some experiments as indicated in the figure legends, naïve CD4 + T cells were FACS-sorted on a FACSAria instrument (BD Biosciences) by the Flow Cytometry Core Facility at the WIBR. Purity was always greater than 98%. Purified CD4 + T cells were used in adoptive transfer (by intravenous injection) experiments or in vitro proliferation assays as indicated in the figure legends.
Generation of mixed bone marrow chimeras TCRabKO host mice were sublethally irradiated (6 Gy) 4 hours before bone marrow reconstitution. Bone marrow cells were harvested from CD45.2 pT reg TN/RKO or CD45.2 OTII Tg/RKO and CD45.1 WT mice and depleted of T cells using CD90.2 MACS beads (Miltenyi) according to the manufacturer's instructions. A total of 5 × 10 6 cells (composed of 2.5 to 10% of CD45.2 cells and 90 to 97.5% of CD45.1 cells) were intravenously injected into host mice. After 12 weeks of reconstitution, T cell development was analyzed in different organs of recipient mice by flow cytometry.
Histopathological analysis
Small and large intestines were fixed in 10% buffered formalin and subjected to hematoxylin and eosin (H&E) staining. Slides were scored blindly by a pathologist from the Division of Comparative Medicine of MIT.
RNA-seq library preparation and sequencing Sorted cells were lysed in a guanidine thiocyanate buffer (Qiagen) supplemented with 1% b-mercaptoethanol. RNA isolated by solid-phase reversible immobilization bead cleanup was reversely transcribed into complementary DNA and preamplified as described (39) . Nextera XT was used to prepare a pooled library of fragmented and uniquely indexed samples. Sequencing was performed on an Illumina HiSeq 2000. For RNA-seq analysis, 40-base pair single-end reads were aligned to the mouse reference genome (mm10) using TopHat. Gene read count was performed using HTseq-count with RefSeq mm10 annotation.
Statistical analysis
Mean and SD values were calculated with GraphPad Prism (GraphPad Software). Unpaired Student's t test was used to compare two variables, as indicated in each figure legend. P values of <0.05 were considered significant and are indicated in the figure or figure legends.
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